Literature DB >> 10603178

Persistence of coxsackievirus B4 infection in rhabdomyosarcoma cells for 30 months. Brief report.

G Frisk1, M A Lindberg, H Diderholm, H Oiderholm.   

Abstract

A persistent infection of rhabdomyosarcoma (RD) cells by Coxsackie B4 virus (CBV-4) was established. The persistently infected RD (piRD) cells have been maintained for over 130 passages (30 months) and have released virus continuously without cellular destruction. The production of infectious virus declined three times during the study. After the first decline (third week post infection) a viral variant with a littered cytopathic effect (CPE) and a marked delayed replication cycle on Green Monkey Kidney (GMK) cells, replaced the original viral population. 100-fold diluted cell cultures were recovered from the piRD cells at the 48(th) and 104(th) passage. All 96 cultures from the former whereas 72% from the second dilution showed virus production when tested on GMK cells. Using a streptavidin/biotin immune-staining assay all piRD cells were positively stained. Test for ts mutants showed that the persistence of the CBV-4 strain was not dependent upon incubation temperature and addition of the antiviral compound disoxaril did not cure the piRD cells.

Entities:  

Mesh:

Year:  1999        PMID: 10603178     DOI: 10.1007/s007050050638

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

Review 1.  Persistent viral infection in primary Sjogren's syndrome: review and perspectives.

Authors:  Antigoni Triantafyllopoulou; Haralampos Moutsopoulos
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

2.  Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor.

Authors:  Hela Jaïdane; Delphine Caloone; Pierre-Emmanuel Lobert; Famara Sane; Olivier Dardenne; Philippe Naquet; Jawhar Gharbi; Mahjoub Aouni; Vincent Geenen; Didier Hober
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

3.  A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.

Authors:  Maria Gullberg; Conny Tolf; Nina Jonsson; Charlotta Polacek; Jana Precechtelova; Miriam Badurova; Martin Sojka; Camilla Mohlin; Stina Israelsson; Kjell Johansson; Shubhada Bopegamage; Susan Hafenstein; A Michael Lindberg
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.

Authors:  Sandra Pinkert; Karin Klingel; Vanessa Lindig; Andrea Dörner; Heinz Zeichhardt; O Brad Spiller; Henry Fechner
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells.

Authors:  Ginger Tsueng; Jenna M Tabor-Godwin; Aparajita Gopal; Chelsea M Ruller; Steven Deline; Naili An; Ricardo F Frausto; Richard Milner; Stephen J Crocker; J Lindsay Whitton; Ralph Feuer
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

6.  The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1.

Authors:  Anna Sävneby; Johannes Luthman; Fabian Nordenskjöld; Björn Andersson; A Michael Lindberg
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.